Author:
Edition: 1
Binding: Hardcover
ISBN: 0470646276
Edition: 1
Binding: Hardcover
ISBN: 0470646276
Fusion Protein Technologies for Biopharmaceuticals: Applications and Challenges
The state of the art in biopharmaceutical FUSION PROTEIN DESIGNFusion proteins belong to the most lucrative biotech drugs-with EnbrelA being one of the best-selling biologics worldwide. Download Fusion Protein Technologies for Biopharmaceuticals: Applications and Challenges from rapidshare, mediafire, 4shared. EnbrelA represents a milestone of modern therapies just as HumulinA, the first therapeutic recombinant protein for human use, approved by the FDA in 1982 and OrthocloneA the first monoclonal antibody reaching the market in 1986. These first generation molecules were soon followed by a plethora of recombinant copies of natural human proteins, and in 1998, the first de novo designed fusion protein was launched.Fusion Protein Technologies for Biopharmaceuticals examines the state of the art in developing fusion proteins for biopharmaceuticals, shedding lig Search and find a lot of engineering books in many category availabe for free download.
Fusion Protein Technologies for Biopharmaceuticals Free
Download Fusion Protein Technologies for Biopharmaceuticals engineering books for free. EnbrelA represents a milestone of modern therapies just as HumulinA, the first therapeutic recombinant protein for human use, approved by the FDA in 1982 and OrthocloneA the first monoclonal antibody reaching the market in 1986 Fusion Protein Technologies for Biopharmaceuticals examines the state of the art in developing fusion proteins for biopharmaceuticals, shedding lig
No comments:
Post a Comment